Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 10/20 | 1.00 |
| ▸ | FTH1 | P02794 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | CNR2 | P34972 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (-)-Caryophyllene Oxide SCHEMBL16489852 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL1532444 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL127077 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL24110118 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL17857878 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL24110084 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL676309 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL16769854 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL21349931 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL26189380 | 1.00 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170119917-A1 | MALODOR REDUCTION COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-05-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119917-A1 | MALODOR REDUCTION COMPOSITIONS | DSG1, LPO, TYR | CYP3A4 212/4885FTH1 3304/4885CYP2C9 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.